11 results · 19ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

RADIATION PROTECTION GLASSES

FDA 510(k)
FDA Class 1 ·Radiology

SCANLAN® Dilators

FDA UDI
SCANLAN INTERNATIONAL INC·00846159031478·Garrett Vascular Dilator

FLOCONTROL , MODEL 1028

FDA 510(k)
FDA Class 2 ·Cardiovascular

STAINLESS STEEL SPINAL SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

CAPSURE SP NOVUS

FDA Adverse Event
Malfunction ·MEDTRONIC, INC.·Product code DTB·June 11, 2010

ADVIA CENTAUR XP

FDA Adverse Event
Malfunction ·SIEMENS HEALTHCARE DIAGNOSTICS, INC.·Product code MMI·June 30, 2014

RESOLUTION HEMOSTASIS CLIPPING DEVICE

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC - MARLBOROUGH·Product code MND·November 17, 2010

HEARTSTART FRX

FDA Adverse Event
Malfunction ·PHILIPS MEDICAL SYSTEMS·Product code MKJ·December 13, 2012

HEART LUNG MACHINE

FDA Adverse Event
Malfunction ·MAQUET CARDIOPULMONARY GMBH·Product code DTQ·April 24, 2020

PM 1250 and PM 2250 ZENEX; PM1282 and PM2282 ZENEX MRI These low voltage (LV) devices are implantable pacemaker pulse generators, intended to be permanently implanted in the body, that have a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. These devices are used as a substitute for the heart's intrinsic pacing system to correct both intermittent and continuous cardiac rhythm disorders.

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017

PM 1260 ASSURITY + These low voltage (LV) devices are implantable pacemaker pulse generators, intended to be permanently implanted in the body, that have a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. These devices are used as a substitute for the heart's intrinsic pacing system to correct both intermittent and continuous cardiac rhythm disorders.

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017